This site uses cookies to offer you a better browsing experience.
Learn more
Pharmaceuticals Bayer: Science For A Better Life

You need commitment, focus and passion to find new ways to fight the diseases of this world: innovation is at the heart of it.

Find us in your country
Find us in your country

Latest press releases

Partnering

From molecules to medicine
From molecules to medicine

  • Cardiovascular
Bayer at ESC Congress 2017

Bayer Receives FDA Approval for Second-Line Systemic Treatment of Liver Cancer

Bayer Receives FDA Approval for Second-Line Systemic Treatment of Liver Cancer

Chagas Disease

Click here to learn more about Chagas and how we’re helping to fight it.
Healthy aging

Healthy aging

Bayer at ISTH 2017

Bayer at ISTH 2017

<span style='font-size:0.75em'>We support the EFPIA campaign</span><br/>#WeWontRest

We support the EFPIA campaign
#WeWontRest

Information about Bayer sponsored clinical studies

Bayer Trial Finder

Clinicaltrials.gov

Data Sharing Portal

News

2017-10-17

Bayer submits its extended half-life hemophilia A compound for marketing authorization in Japan

2017-10-16

Bayer to present latest clinical data of Vilaprisan at ESG 2017

2017-10-05

Bayer’s NAVIGATE ESUS study halted early as it indicated comparable efficacy between treatment arms

2017-09-26

Bayer supports improved access to information for sexuality education

2017-09-15

Bayer receives positive CHMP opinion for rivaroxaban 10 mg once daily for the extended prevention of venous thromboembolism
Press center